India’s weight-loss drug rush kicks off with generics 50-90% cheaper
Top drugmakers roll out cheaper semaglutide within a day of patent expiry, triggering a scramble for share in India's weight-loss and diabetes market.
Top drugmakers roll out cheaper semaglutide within a day of patent expiry, triggering a scramble for share in India's weight-loss and diabetes market.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
